Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Perl

Showing results (211-220 of 241) with videos related to

Pageof 25
Sort By:
Nature Communications|September 27, 2023
Omicron variant neutralizing antibodies following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney diseaseKevin Yau, Alexandra Kurtesi, Freda Qi, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|October 27, 2025
Incremental start and clinical outcomes in peritoneal dialysis: International results from PDOPPSAshik Hayat, Melissa S Cheetham, Yeoungjee Cho, et al.
Kidney International|June 16, 2019
An international Delphi survey helped develop consensus-based core outcome domains for trials in peritoneal dialysisKarine E Manera, Allison Tong, Jonathan C Craig, et al.
Plos One|May 24, 2022
Predictors and outcomes of peritoneal dialysis-related infections due to filamentous molds (MycoPDICS)Talerngsak Kanjanabuch, Tanawin Nopsopon, Tanittha Chatsuwan, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 4, 2022
Differences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine immunogenicity among patients undergoing dialysisKevin Yau, Christopher T Chan, Kento T Abe, et al.
JAMA Network Open|September 2, 2021
Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing HemodialysisKevin Yau, Kento T Abe, David Naimark, et al.
Kidney International Reports|August 15, 2022
Establishing a Core Outcome Measure for Peritoneal Dialysis-related Peritonitis: A Standardized Outcomes in Nephrology-Peritoneal Dialysis Consensus Workshop ReportJenny I Shen, Yeoungjee Cho, Karine E Manera, et al.
Canadian Journal of Kidney Health and Disease|March 23, 2023
Determining the Longitudinal Serologic Response to COVID-19 Vaccination in the Chronic Kidney Disease Population: A Clinical Research ProtocolKevin Yau, Omosomi Enilama, Adeera Levin, et al.
Diabetes Care|June 26, 2025
Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Emergency Department Visits and Hospitalization in Patients With Chronic Kidney DiseaseKevin Yau, Joel G Ray, Nivethika Jeyakumar, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 18, 2020
"Can I go to Glasgow?" Learnings from patient involvement at the 17th Congress of the International Society for Peritoneal Dialysis (ISPD)Talia Gutman, Karine E Manera, Amanda Baumgart, et al.
Pageof 25

Showing results (211-220 of 241) with videos related to

Sort By:
Pageof 25
Nature Communications|September 27, 2023
Omicron variant neutralizing antibodies following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney diseaseKevin Yau, Alexandra Kurtesi, Freda Qi, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|October 27, 2025
Incremental start and clinical outcomes in peritoneal dialysis: International results from PDOPPSAshik Hayat, Melissa S Cheetham, Yeoungjee Cho, et al.
Kidney International|June 16, 2019
An international Delphi survey helped develop consensus-based core outcome domains for trials in peritoneal dialysisKarine E Manera, Allison Tong, Jonathan C Craig, et al.
Plos One|May 24, 2022
Predictors and outcomes of peritoneal dialysis-related infections due to filamentous molds (MycoPDICS)Talerngsak Kanjanabuch, Tanawin Nopsopon, Tanittha Chatsuwan, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 4, 2022
Differences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine immunogenicity among patients undergoing dialysisKevin Yau, Christopher T Chan, Kento T Abe, et al.
JAMA Network Open|September 2, 2021
Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing HemodialysisKevin Yau, Kento T Abe, David Naimark, et al.
Kidney International Reports|August 15, 2022
Establishing a Core Outcome Measure for Peritoneal Dialysis-related Peritonitis: A Standardized Outcomes in Nephrology-Peritoneal Dialysis Consensus Workshop ReportJenny I Shen, Yeoungjee Cho, Karine E Manera, et al.
Canadian Journal of Kidney Health and Disease|March 23, 2023
Determining the Longitudinal Serologic Response to COVID-19 Vaccination in the Chronic Kidney Disease Population: A Clinical Research ProtocolKevin Yau, Omosomi Enilama, Adeera Levin, et al.
Diabetes Care|June 26, 2025
Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Emergency Department Visits and Hospitalization in Patients With Chronic Kidney DiseaseKevin Yau, Joel G Ray, Nivethika Jeyakumar, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 18, 2020
"Can I go to Glasgow?" Learnings from patient involvement at the 17th Congress of the International Society for Peritoneal Dialysis (ISPD)Talia Gutman, Karine E Manera, Amanda Baumgart, et al.
Pageof 25